Skip to content

Human Papillomavirus (HPV) infection in young men who have sex with men

HPV infection in young men who have sex with men

Status
Completed
Phases
Unknown
Study type
Observational
Source
ANZCTR
Registry ID
ACTRN12611000857909
Acronym
HYPER
Enrollment
200
Registered
2011-08-12
Start date
2010-09-20
Completion date
2011-08-24
Last updated
2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

Studies indicate that men who have sex with men (MSM) have a high prevalence of anogenital Human papillomavirus (HPV) infection and increased risk for HPV related anogenital lesions including anogenital warts, anal intraepithelial neoplasia ( the abnormal proliferation of cells) and anal cancer. Currently in Australia, HPV vaccine for men is not covered by programs. This study will explore the prevalence of persistent HPV infection, distinguishing this from transient HPV infection and sexual behaviours associated with varying prevalence of HPV infection. We will survey 200 MSM aged 16-20 who just started their sexual life. We will use a questionnaire to collect information of socio-demographic characteristics, lifetime sexual experience, recent sexual experience, the most recent sexual contact, STIs/HIV history and testing history, HPV knowledge and attitude, smoking/alcohol/drug/circumcision. We will also collect oral, penile and anal samples as well as blood samples to test for HPV DNA, mRNA and antibody. The study will include four visits in the 12-month period. In each visit, participants will be asked to fill a questionnaire and provide oral, penile and anal samples as well as blood samples. Each participant will receive $25 at each visit as compensation for their time. All participants will be offered free HPV vaccine at the end of the study.

Interventions

Cohort study of HPV infection over a 12 month period. Each participant will have a three samples taken for HPV DNA (genital, throat, and anal) and serology taken for HPV DNA antibodies. These samples (HPV DNA and serology) will be taken at base line, 3 months, 6 months, and 12 months (4 time periods).

Sponsors

Alfred Hospital
Lead SponsorHospital

Eligibility

Sex/Gender
Male
Age
16 Years to 20 Years
Healthy volunteers
Yes

Inclusion criteria

Men aged 16 to 20 Report previous sexual contact (any type of sexual contact) with at least one other man ever Able to complete all study requirements including questionnaire in English and completion of 4 visits

Exclusion criteria

NIL

Outcome results

None listed

Source: ANZCTR · Data processed: Mar 19, 2026